HIV

Approximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.

Global HIV incidence rates drop in some African countries.

Prior research suggested that T cells become pathogenic when they encounter specific dendritic cells in the lymph nodes.

Clinicians are able to prescribe ART more liberally for HIV because of its improved adverse event profile and wider array of available drugs.

The recommended time to begin antiretroviral therapy has changed since it first arrived in the mid 90s for HIV.

Study cautions against unintended consequences of “shock and kill” treatment for HIV.

The recommended time to begin antiretroviral therapy (called the ART-start threshold) has changed since ART first arrived in the mid 90s. Now, clinicians are able to prescribe ART more liberally because of its improved adverse event profile and wider array of available drugs.

Peer referrals for testing can locate people with undiagnosed HIV better than health care providers.

Portal hypertension creates problems in patients coinfected with HIV and hepatitis C virus.

Patients who have both HIV and hepatitis C, and also have portal hypertension, are a very special concern.

Patients who have human immunodeficiency virus (HIV) infection are at elevated risk for HCV.

Cigarettes can be a bigger contributor to death in HIV patients than the virus itself.

Advances in the support of patients with HIV include remarkable new pharmaceutical therapies, collaborative care, outstanding patient support, and medication management.

Experimental HIV vaccine could provide long-term protection in areas with high infection rates.

Researchers seek to determine the best antiretroviral treatment regimen for HIV.

Finding the right combinations for antiretroviral therapy for HIV remains a challenge for researchers.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

New testing procedure can quickly evaluate HIV levels in the blood.

Optimal treatment to prevent mother-to-child transmission of HIV can increase adverse events.

Link between HIV and cancer established in new report.

In this week's "Around the Web," Pharmacy Times presents a video that was recently posted by the World Health Organization, which discusses self-testing options for HIV.

Newly developed technology maps HIV inserts across the human genome.

Around 14 million people have HIV worldwide – yet an estimated 40% don’t know they’re infected.

CDC officials now recommend routine use of the meningococcal conjugate vaccine for patients with HIV.

Study captures major changes in infectious diseases between 1980 through 2014.

The cost of providing essential medications may not be too costly in low- and middle-income countries.

December 1 is observed as World AIDS Day.

New progress made towards the development of an HIV vaccine.

Top news of the day from across the health care landscape.